The Global Vagus Nerve Stimulators Market Growth Accelerated By Digital Transformation

https://www.coherentmarketinsights.com/market-insight/vagus-nerve-stimulators-market-2514
Vagus Nerve Stimulators Market


Vagus nerve stimulators are implantable devices used for treating various medical conditions such as epilepsy, depression, and inflammatory bowel disease by stimulating the vagus nerve.These devices help in managing medication-resistant symptoms in epilepsy patients and aid in reducing the frequency and severity of seizures. Various advantages associated with these devices include small size, minimal surgical risk, improved mood and quality of life of patients, and better treatment outcomes.

The global Vagus Nerve Stimulators Market is estimated to be valued at US$ 684.85 Mn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends

The adoption of digital technologies is one the key trends driving the growth of the vagus nerve stimulators market. There is a rise in preference of wireless and smart vagus nerve stimulators that can be controlled remotely through digital devices like smartphones. Features like cloud connectivity and real-time data sharing allow physicians to optimize treatment based on patient performance. These digital vagus nerve stimulators offer benefits like enhanced functionality, remote monitoring and programming options, data collection for better decision-making. Growing technological advancements like use of artificial intelligence for designing novel stimulation devices by gathering patient data will make treatment more personalized. This digital transformation trend in medical devices offers improved care and is expected to proliferate the adoption of vagus nerve stimulators during the forecast period.

Segment Analysis

The global Vagus Nerve Stimulators Market Share is dominated by the Implantable Vagus Nerve Stimulation Devices segment. Vagus nerve stimulation therapy is primarily used for treatment-resistant depression and epilepsy, with implantable devices providing effective long-term treatment for patients suffering from these conditions. Implantable vagus nerve stimulators offer controlled and continuous stimulation of the vagus nerve, thereby better managing treatment-resistant cases of epilepsy and depression over traditional methods.

Key Takeaways

The global vagus nerve stimulators market is expected to witness high growth over the forecast period of 2023 to 2030. North America currently dominates the global market with the highest revenue share. This is attributed to favorable reimbursement policies and higher adoption rates for vagus nerve stimulation therapy.

Key players operating in the vagus nerve stimulators market are LivaNova PLC, electroCore, Inc., SetPoint Medical Corporation, Beijing PINS Medical Co., Ltd., Parasym Ltd., Nervana, LLC, tVNS Technologies GmbH, BioControl Medical, NeurAxis, Inc., Soterix Medical Inc., MicroTransponder Inc., Boston Scientific Corporation, Cyberonics, Inc., EnteroMedics Inc., ReShape Lifesciences Inc., and Cerbomed GmbH.

Key players operating in the vagus nerve stimulators market are focusing on product innovations and new product launches. Partnerships with research institutions are helping companies expand indications and enhance clinical evidence for vagus nerve stimulation therapy. Increasing investments aimed at the development of less invasive and more targeted stimulation devices present lucrative growth opportunities in the global market over the coming years.

Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries